Morinidazole

吗啉硝唑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameMorinidazole
Drug Alias Name迈灵达
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Nitroimidazole antibiotics
Mechanisms of ActionDNA inhibitors
TargetsDNA
Therapy Area/IndicationsEndometritisSalpingitisFallopian Tube Diseases +[7] 
Global Approved IndicationsPelvic Inflammatory Disease
Approved Indications in ChinaPelvic Inflammatory Disease
Original Approved Country/TerritoryMainland China
Original Approved Date2014/02/24
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hansoh Pharmaceutical Group Co Ltd
Inactive CompaniesN/A
Active IndicationsEndometritisSalpingitisFallopian Tube Diseases +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01
Related LinksN/A